Andean Precious Metals (CVE:APM) Stock Price Down 9.6% - Should You Sell?

Andean Precious Metals Corp. (CVE:APM - Get Free Report) was down 9.6% during mid-day trading on Tuesday . The company traded as low as C$1.12 and last traded at C$1.13. Approximately 288,829 shares traded hands during trading, an increase of 50% from the average daily volume of 191,939 shares. The stock had previously closed at C$1.25.

Wall Street Analysts Forecast Growth

Separately, Desjardins raised Andean Precious Metals to a "moderate buy" rating in a research note on Thursday, October 31st.

Andean Precious Metals Trading Down 10.4 %

The firm's 50-day simple moving average is C$1.43 and its two-hundred day simple moving average is C$1.25. The stock has a market capitalization of C$167.28 million, a PE ratio of 2.95 and a beta of 1.22.

Insider Activity

In related news, insider 2176423 Ontario Ltd. acquired 213,800 shares of the stock in a transaction that occurred on Wednesday, October 2nd. The shares were purchased at an average cost of C$1.38 per share, with a total value of C$294,530.88. Over the last quarter, insiders have acquired 306,200 shares of company stock worth $432,953. 69.37% of the stock is owned by corporate insiders.

Andean Precious Metals Company Profile

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.